Cutera EBIT per Share
Delisted
The EBIT per Share of Cutera (CUTRQ) as of Sep 9, 2026 is -7.86 USD. In the previous year, EBIT per Share was -2.04 USD — a change of 284.61% (lower).
Get this data via API
Financial Data API
EBIT per Share
-7.86USD
YoY
284.61%
Last updated:
EBIT per Share of Cutera is 2026 -7.86 USD. EBIT per Share of Cutera was 2025 -2.04 USD. It decreases by 284.61% lower compared to the previous year.
The Cutera EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2019
-0.86 USD
Jan 1, 2020
-1.37 USD
Jan 1, 2021
0.11 USD
Jan 1, 2022
-2.04 USD
Jan 1, 2023
-7.86 USD
Jan 1, 2024 (e)
-4.78 USD
Jan 1, 2025 (e)
-3.24 USD
Jan 1, 2026 (e)
-2.36 USD
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | -2.36USD | -27.29% |
| est | -3.24USD | -32.13% |
| est | -4.78USD | -39.18% |
| -7.86USD | +284.61% | |
| -2.04USD | -1,979.36% | |
| 0.11USD | -107.96% | |
| -1.37USD | +59.09% | |
| -0.86USD | -11.62% | |
| -0.97USD | -301.04% | |
| 0.48USD | +177.72% | |
| 0.17USD | -154.11% | |
| -0.32USD | -56.64% | |
| -0.74USD | +101.40% | |
| -0.37USD | -23.68% | |
| -0.48USD | -36.01% | |
| -0.75USD | -8.34% | |
| -0.82USD | +16.34% | |
| -0.71USD | +191.83% | |
| -0.24USD | -135.82% | |
| 0.68USD | -40.32% | |
| 1.13USD | -5.71% | |
| 1.20USD | +181.88% | |
| 0.43USD | — |
Access this data via the Eulerpool API
Cutera Stock analysis
What does Cutera do? Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. The company was founded in California in 1998 and has since had a successful history in the beauty and medical care industry.
Cutera's business model consists of developing and selling innovative laser devices used in the cosmetics and medical industries. The company's goal is to offer its customers (doctors, beauty clinics, etc.) the latest and most effective laser technologies to meet the needs and expectations of their patients.
In recent years, Cutera has focused on several areas to offer its customers a wider range of products. These include skin rejuvenation, body contouring, hair removal, vascular and pigmented lesions, scar treatment, and tattoo removal. The company has over 20 different products in its portfolio, all tailored to the needs of different patient groups.
In the field of skin rejuvenation, Cutera offers variants such as Laser Genesis Plus, Genesis V, Excel HR, and other lasers to treat wrinkles, fine lines, pigment irregularities, and texture problems. Body contouring is made possible through devices such as Sculpture and TruSculpt 3D. Hair removal is supported by the ProWave, CoolGlide, and XEO system. Treatment of vascular and pigmented lesions is done through devices such as Excel HR, LimeLight, and the XEO system. For scar treatment and tattoo removal, lasers such as Enlighten and Genesis V are used.
Cutera has gained an excellent reputation in the industry through its innovative products and sustainable business philosophy. The company aims to meet the needs and expectations of its customers by providing innovative technologies, high-quality products, and outstanding customer service. Cutera continually invests in research and development to ensure that it can always offer its customers the latest and best laser devices. Additionally, the company places great importance on the safety of its products and has specialized in training and education for its customers and users.
Recently, Cutera Inc. has also made strides in telemedicine to better support its customers. This allows doctors and users to access support anytime and anywhere, for example, for training and technical support.
In summary, Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. Its wide range of products tailored to the different needs and expectations of patients has earned it an excellent reputation in the industry. Cutera continuously invests in research and development, offers outstanding customer service, and places great importance on the safety of its products. In the future, the company will continue to develop innovative technologies, revolutionizing beauty and medical care. Cutera is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Cutera stock
EBIT per Share of Cutera is -7.86 USD in 2026.
EBIT per Share of Cutera changed from -2.04 USD to -7.86 USD, representing a 284.61% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Cutera since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Cutera
All Key Metrics — Cutera
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth